646
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma

, , , &
Pages 59-69 | Received 16 Jun 2014, Accepted 23 Dec 2014, Published online: 06 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yuliya Semenova & Geir Bjørklund. (2023) Antioxidants and neurodegenerative eye disease. Critical Reviews in Food Science and Nutrition 0:0, pages 1-19.
Read now
Ningmin Zhao, Jieran Shi, Haohang Xu, Qing Luo, Qiaoyan Li & Mingzhou Liu. (2021) Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo. Bioengineered 12:2, pages 10187-10198.
Read now
Sümeyye Burcu Agcayazi, Adem Ugurlu, Turgay Ucak, Nurdan Gamze Tasli, Yucel Karakurt, Erel Icel, Ferda Keskin Cimen & Halis Süleyman. (2021) Protection against experimental cisplatin-induced optic nerve toxicity using resveratrol: A rat model study. Cutaneous and Ocular Toxicology 40:3, pages 263-267.
Read now
Hyemin Seong, Jinhyun Ryu, Woong-Sun Yoo, Seong Jae Kim, Yong‑Seop Han, Jong Moon Park, Sang Soo Kang & Seong Wook Seo. (2017) Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3. Current Eye Research 42:12, pages 1650-1658.
Read now

Articles from other publishers (49)

Elsa Wilma Böhm, Francesco Buonfiglio, Anna Maria Voigt, Philipp Bachmann, Tarek Safi, Norbert Pfeiffer & Adrian Gericke. (2023) Oxidative stress in the eye and its role in the pathophysiology of ocular diseases. Redox Biology 68, pages 102967.
Crossref
Alessandra Boccaccini, Dario Cavaterra, Carmela Carnevale, Lucia Tanga, Stefano Marini, Alessio Bocedi, Pedro M. Lacal, Gianluca Manni, Grazia Graziani, Diego Sbardella & Grazia Raffaella Tundo. (2023) Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects. Molecular Aspects of Medicine 94, pages 101225.
Crossref
Francesco Buonfiglio, Norbert Pfeiffer & Adrian Gericke. (2023) Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment. Pharmaceuticals 16:9, pages 1193.
Crossref
James R. Tribble, Flora Hui, Heberto Quintero, Sana El Hajji, Katharina Bell, Adriana Di Polo & Pete A. Williams. (2023) Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering. Molecular Aspects of Medicine 92, pages 101193.
Crossref
Jing Yan & Hilmar Bading. (2023) The Disruption of NMDAR/TRPM4 Death Signaling with TwinF Interface Inhibitors: A New Pharmacological Principle for Neuroprotection. Pharmaceuticals 16:8, pages 1085.
Crossref
Francesco Buonfiglio, Elsa Wilma Böhm, Norbert Pfeiffer & Adrian Gericke. (2023) Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?. Antioxidants 12:7, pages 1465.
Crossref
Sheena E.B. Tyler & Luke D.K. Tyler. (2023) Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases. IBRO Neuroscience Reports 14, pages 210-234.
Crossref
Mutali Musa, Marco Zeppieri, George Nnamdi Atuanya, Ehimare S. Enaholo, Efioshiomoshi Kings Topah, Oluwasola Michael Ojo & Carlo Salati. (2023) Nutritional Factors: Benefits in Glaucoma and Ophthalmologic Pathologies. Life 13:5, pages 1120.
Crossref
Makoto Ishikawa, Yukitoshi Izumi, Kota Sato, Taimu Sato, Charles F. Zorumski, Hiroshi Kunikata & Toru Nakazawa. (2023) Glaucoma and microglia-induced neuroinflammation. Frontiers in Ophthalmology 3.
Crossref
Asami Mori, Yuna Ezawa, Daiki Asano, Toshiki Kanamori, Akane Morita, Toshihide Kashihara, Kenji Sakamoto & Tsutomu Nakahara. (2023) Resveratrol dilates arterioles and protects against N-methyl-d-aspartic acid-induced excitotoxicity in the rat retina. Neuroscience Letters 793, pages 136999.
Crossref
María del Carmen Villegas-Aguilar, María de la Luz Cádiz-Gurrea, David Arráez-Román & Antonio Segura-Carretero. 2023. Anti-Aging Pharmacology. Anti-Aging Pharmacology 119 152 .
Lidawani Lambuk, Nurfatihah Azlyna Ahmad Suhaimi, Muhammad Zulfiqah Sadikan, Azliana Jusnida Ahmad Jafri, Suhana Ahmad, Nurul Alimah Abdul Nasir, Vuk Uskoković, Ramlah Kadir & Rohimah Mohamud. (2022) Nanoparticles for the treatment of glaucoma-associated neuroinflammation. Eye and Vision 9:1.
Crossref
Isabel Pinilla, Victoria Maneu, Laura Campello, Laura Fernández-Sánchez, Natalia Martínez-Gil, Oksana Kutsyr, Xavier Sánchez-Sáez, Carla Sánchez-Castillo, Pedro Lax & Nicolás Cuenca. (2022) Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications. Antioxidants 11:6, pages 1086.
Crossref
Mahin Jawad, Maham Jawad, Hafiza Nazia, Filza Khalid Khan, Arifa Ishaq & Kinza Khan. (2022) Resveratrol: A Phenolic Prodigy. Pakistan BioMedical Journal.
Crossref
Paolin Rocio Cáceres-Vélez, Flora Hui, Julie Hercus, Bang Bui & Patricia Regina Jusuf. (2022) Restoring the oxidative balance in age-related diseases – An approach in glaucoma. Ageing Research Reviews 75, pages 101572.
Crossref
Ru Hui Sim, Srinivasa Rao Sirasanagandla, Srijit Das & Seong Lin Teoh. (2022) Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update. Nutrients 14:3, pages 534.
Crossref
MaríaF González Fleitas, Damián Dorfman & RuthE Rosenstein. (2022) A novel viewpoint in glaucoma therapeutics: enriched environment. Neural Regeneration Research 17:7, pages 1431.
Crossref
Syed Shoeb Ahmad, Syed Mohammed Bilal, Anam Tariq & Aliya Rashid. (2022) Dietary Intervention in Glaucoma. US Ophthalmic Review 16:1, pages 22.
Crossref
Gerard Esteruelas, Lyda Halbaut, Victor García-Torra, Marta Espina, Amanda Cano, Miren Ettcheto, Antoni Camins, Eliana B. Souto, Maria Luisa García & Elena Sánchez-López. (2022) Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. International Journal of Pharmaceutics 612, pages 121379.
Crossref
Jacek Dziedziak, Kaja Kasarełło & Agnieszka Cudnoch-Jędrzejewska. (2021) Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma. Antioxidants 10:11, pages 1743.
Crossref
Kaibao Ji, Zongyuan Li, Yiming Lei, Wanxin Xu, Lingyi Ouyang, Tao He & Yiqiao Xing. (2021) Resveratrol attenuates retinal ganglion cell loss in a mouse model of retinal ischemia reperfusion injury via multiple pathways. Experimental Eye Research 209, pages 108683.
Crossref
Sayena Jabbehdari, Judy L Chen & Thasarat Sutabutr Vajaranant. (2020) Effect of dietary modification and antioxidant supplementation on intraocular pressure and open-angle glaucoma. European Journal of Ophthalmology 31:4, pages 1588-1605.
Crossref
Kevin Y. Zhang, Erika A. Aguzzi & Thomas V. Johnson. (2021) Retinal Ganglion Cell Transplantation: Approaches for Overcoming Challenges to Functional Integration. Cells 10:6, pages 1426.
Crossref
Aina Liz A. Cesar, Larissa Caldeira Navarro, Rachel Oliveira Castilho, Gisele Assis Castro Goulart, Giselle Foureaux, Anderson J. Ferreira, Sebastião Cronemberger & André Augusto Gomes Faraco. (2020) New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study. Journal of Biomedical Materials Research Part A 109:3, pages 336-345.
Crossref
Dominique Delmas, Clarisse Cornebise, Flavie Courtaut, Jianbo Xiao & Virginie Aires. (2021) New Highlights of Resveratrol: A Review of Properties against Ocular Diseases. International Journal of Molecular Sciences 22:3, pages 1295.
Crossref
T. N. Kiseleva, A. V. Chudin, N. V. Balatskaya, A. I. Shchipanova, I. P. Khoroshilova-Maslova, M. S. Zaytsev, A. M. Maybogin & K. V. Lugovkina. (2020) An experimental study of resveratrol effect on neurotrophic and structural changes in retinal ischemia. Russian Ophthalmological Journal 13:4, pages 39-47.
Crossref
Yue Wu, Yulian Pang, Wei Wei, An Shao, Cong Deng, Xiongfeng Li, Haoyu Chang, Piaopiao Hu, Xuequn Liu & Xu Zhang. (2020) Resveratrol protects retinal ganglion cell axons through regulation of the SIRT1-JNK pathway. Experimental Eye Research 200, pages 108249.
Crossref
Jose Javier Garcia-Medina, Elena Rubio-Velazquez, Maria Dolores Lopez-Bernal, Alejandro Cobo-Martinez, Vicente Zanon-Moreno, Maria Dolores Pinazo-Duran & Monica del-Rio-Vellosillo. (2020) Glaucoma and Antioxidants: Review and Update. Antioxidants 9:11, pages 1031.
Crossref
Chun-Ping Huang, Yi-Wen Lin, Yu-Chuen Huang & Fuu-Jen Tsai. (2020) Mitochondrial Dysfunction as a Novel Target for Neuroprotective Nutraceuticals in Ocular Diseases. Nutrients 12:7, pages 1950.
Crossref
Kejia Cao, Tomoka Ishida, Yuxin Fang, Kosei Shinohara, Xuejiao Li, Natsuko Nagaoka, Kyoko Ohno-Matsui & Takeshi Yoshida. (2020) Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension. Investigative Opthalmology & Visual Science 61:3, pages 13.
Crossref
Jinyuan Luo, Tao He, Jiayi Yang, Ning Yang, Zongyuan Li & Yiqiao Xing. (2020) SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice. Graefe's Archive for Clinical and Experimental Ophthalmology 258:2, pages 335-344.
Crossref
Radhika Pooja Patel, Ehtesham Shamsher, Daniel Hill & Maria Francesca Cordeiro. 2020. Glaucoma: A Neurodegenerative Disease of the Retina and Beyond - Part B. Glaucoma: A Neurodegenerative Disease of the Retina and Beyond - Part B 119 140 .
Selom Avotri, Danita Eatman & Karen Russell-Randall. (2019) Effects of Resveratrol on Inflammatory Biomarkers in Glaucomatous Human Trabecular Meshwork Cells. Nutrients 11:5, pages 984.
Crossref
Vasanti Suvarna, Megha Sarkar, Pramila Chaubey, Manikanta Murahari & Preeti C. Sangave. 2019. Handbook of Nutrition, Diet, and the Eye. Handbook of Nutrition, Diet, and the Eye 221 230 .
Shu-Yan Liu, Jing-Yao Song, Bin Fan, Ying Wang, Yi-Ran Pan, Lin Che, Ying-Jian Sun & Guang-Yu Li. (2018) Resveratrol protects photoreceptors by blocking caspase- and PARP-dependent cell death pathways. Free Radical Biology and Medicine 129, pages 569-581.
Crossref
Marita Pietrucha-Dutczak, Marialaura Amadio, Stefano Govoni, Joanna Lewin-Kowalik & Adrian Smedowski. (2018) The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration. Frontiers in Neuroscience 12.
Crossref
Mehdi Koushki, Nasrin Amiri‐Dashatan, Nayebali Ahmadi, Hojjat‐Allah Abbaszadeh & Mostafa Rezaei‐Tavirani. (2018) Resveratrol: A miraculous natural compound for diseases treatment. Food Science & Nutrition 6:8, pages 2473-2490.
Crossref
Hongdou Luo, Jiejie Zhuang, Piaopiao Hu, Wei Ye, Shanshan Chen, Yulian Pang, Ningfeng Li, Cong Deng & Xu Zhang. (2018) Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury. Investigative Opthalmology & Visual Science 59:10, pages 3879.
Crossref
Xi Zhang, Yifan Feng, Yuping Wang, Jing Wang, Danni Xiang, Weiran Niu & Fei Yuan. (2018) Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model. Life Sciences 207, pages 234-245.
Crossref
Najam A. Sharif. (2018) i Drugs and i Devices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants . Journal of Ocular Pharmacology and Therapeutics 34:1-2, pages 7-39.
Crossref
Shaoqing HeDorota L. StankowskaDorette Z. EllisRaghu R. KrishnamoorthyThomas Yorio. (2018) Targets of Neuroprotection in Glaucoma. Journal of Ocular Pharmacology and Therapeutics 34:1-2, pages 85-106.
Crossref
Eduardo Ruiz-Pesini, Sonia Emperador, Ester López-Gallardo, Carmen Hernández-Ainsa & Julio Montoya. (2018) Increasing mtDNA levels as therapy for mitochondrial optic neuropathies. Drug Discovery Today 23:3, pages 493-498.
Crossref
Lawson Ung, Ushasree Pattamatta, Nicole Carnt, Jennifer L. Wilkinson-Berka, Gerald Liew & Andrew J.R. White. (2017) Oxidative stress and reactive oxygen species: a review of their role in ocular disease. Clinical Science 131:24, pages 2865-2883.
Crossref
Murali Subramani, Murugeswari Ponnalagu, Lekshmi Krishna, Nallathambi Jeyabalan, Priyanka Chevour, Anupam Sharma, Chaitra Jayadev, Rohit Shetty, Nargis Begum, Govindaraju Archunan & Debashish Das. (2017) Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells. Scientific Reports 7:1.
Crossref
Raffaele Nuzzi & Federico Tridico. (2017) Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis. Frontiers in Neuroscience 11.
Crossref
Saravanakumar Pandian, Vinoth Jeevanesan, Chandrasekar Ponnusamy & Subramanian Natesan. (2016) RES‐loaded pegylated CS NPs: for efficient ocular delivery. IET Nanobiotechnology 11:1, pages 32-39.
Crossref
Dario Rusciano, Salvatore Pezzino, Maria Giulia Mutolo, Rossella Giannotti, Aloisa Librando & Nicola Pescosolido. (2017) Neuroprotection in Glaucoma: Old and New Promising Treatments. Advances in Pharmacological Sciences 2017, pages 1-19.
Crossref
Khaled Abu-Amero, Altaf Kondkar & Kakarla Chalam. (2016) Resveratrol and Ophthalmic Diseases. Nutrients 8:4, pages 200.
Crossref
Thirumurthy Velpandian, Aruna Singh & Rama Jayasundar. 2016. Pharmacology of Ocular Therapeutics. Pharmacology of Ocular Therapeutics 517 535 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.